Norges Bank Biotechnology

Norges Bank

$736 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AGIO Agios Pharmaceuticals, Inc.	$1.88B	$4.77 Million 0.0% of portfolio	145,092	Q4 2024 New
TERN Terns Pharmaceuticals, Inc.	$141M	$4.74 Million 0.0% of portfolio	849,389	Q4 2024 New
MDXG Mimedx Group, Inc.	$910M	$4.02 Million 0.0% of portfolio	417,900	Q4 2024 New
BCRX Biocryst Pharmaceuticals Inc	$1.57B	$3.95 Million 0.0% of portfolio	524,804	Q4 2024 New
ABCL Ab Cellera Biologics Inc.	$833M	$3.76 Million 0.0% of portfolio	1,284,533	Q4 2024 New
KYMR Kymera Therapeutics, Inc.	$1.65B	$3.67 Million 0.0% of portfolio	91,231	Q4 2024 New
RGNX Regenxbio Inc.	$285M	$3.47 Million 0.0% of portfolio	449,400	Q4 2024 New
STOK Stoke Therapeutics, Inc.	$326M	$3.47 Million 0.0% of portfolio	314,800	Q4 2024 New
XNCR Xencor Inc	$894M	$3.4 Million 0.0% of portfolio	147,823	Q4 2024 New
GLPG Galapagos Nv	$1.73B	$3.3 Million 0.0% of portfolio	120,000	Q4 2024 New
GLUE Monte Rosa Therapeutics, Inc.	$270M	$3.09 Million 0.0% of portfolio	445,868	Q4 2024 New
IOVA Iovance Biotherapeutics, Inc.	$830M	$3.08 Million 0.0% of portfolio	416,237	Q4 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$155M	$2.79 Million 0.0% of portfolio	500,823	Q4 2024 New
TSHA Taysha Gene Therapies, Inc.	$78.3M	$2.53 Million 0.0% of portfolio	1,461,120	Q4 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$693M	$2.14 Million 0.0% of portfolio	169,000	Q4 2024 New
ACLX Arcellx, Inc.	$2.67B	$2.08 Million 0.0% of portfolio	27,251	Q4 2024 New
VERA Vera Therapeutics, Inc.	$751M	$2.05 Million 0.0% of portfolio	48,593	Q4 2024 New
ADMA Adma Biologics, Inc.	$3.1B	$2.05 Million 0.0% of portfolio	119,344	Q4 2024 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.23B	$1.92 Million 0.0% of portfolio	91,770	Q4 2024 New
SMMT Summit Therapeutics Inc.	$3.66B	$1.79 Million 0.0% of portfolio	100,000	Q4 2024 New
INVA Innoviva, Inc.	$1.22B	$1.48 Million 0.0% of portfolio	85,282	Q4 2024 New
EWTX Edgewise Therapeutics, Inc.	$1.62B	$1.28 Million 0.0% of portfolio	47,755	Q4 2024 New
WVE Wave Life Sciences Ltd.	$920M	$1.24 Million 0.0% of portfolio	100,000	Q4 2024 New
TVTX Travere Therapeutics, Inc.	$1.32B	$1.24 Million 0.0% of portfolio	71,000	Q4 2024 New
KROS Keros Therapeutics, Inc.	$282M	$1.03 Million 0.0% of portfolio	64,900	Q4 2024 New
PRTA Prothena Corp Public LTD CO	$710M	$795,000 0.0% of portfolio	57,454	Q4 2024 New
VNDA Vanda Pharmaceuticals Inc.	$266M	$550,000 0.0% of portfolio	115,000	Q4 2024 New
RCUS Arcus Biosciences, Inc.	$713M	$506,000 0.0% of portfolio	34,044	Q4 2024 New
BEAM Beam Therapeutics Inc.	$1.91B	$461,000 0.0% of portfolio	18,591	Q4 2024 New
VERV Verve Therapeutics, Inc.	$372M	$440,000 0.0% of portfolio	78,186	Q4 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$413,000 0.0% of portfolio	161,000	Q4 2024 New
ACET Adicet Bio, Inc.	$36M	$412,000 0.0% of portfolio	429,550	Q4 2024 New
NTLA Intellia Therapeutics, Inc.	$825M	$349,000 0.0% of portfolio	30,010	Q4 2024 New
ENTA Enanta Pharmaceuticals Inc	$163M	$234,000 0.0% of portfolio	40,700	Q4 2024 New
BCAB Bio Atla, Inc.	$12.3M	$229,000 0.0% of portfolio	389,100	Q4 2024 New
APLT Applied Therapeutics Inc.	$25.5M	$206,000 0.0% of portfolio	243,200	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.